The ER status in the breast tumor cells was assessed in a study by Mirtavoos-Mahyari et al. (2014) to determine how it affected the activation of the tyrosine kinase human epidermal growth factor receptor 2 (HER2). The gene discussed is ERBB2; the disease is breast neoplasm.